Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019)

Perrigo's (PRGO) quarterly Net Equity Issued and Repurchased came in at $200000.0 in Q4 2019, down 33.33% year-on-year from $300000.0 in Q4 2018, and down 50.0% on a QoQ basis from $400000.0 in Q3 2019.

Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019) Analysis & Trends

Perrigo (PRGO) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $200000.0 in Q4 2019.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 33.33% year-over-year to $200000.0 in Q4 2019; TTM through Dec 2020 was $600000.0, a 68.42% decrease from a year earlier, with the FY2019 full-year figure at $900000.0, down 30.77% from the prior year.
  • Net Equity Issued and Repurchased for Q4 2019 stood at $200000.0, down from $400000.0 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for PRGO reached as high as $6.2 million in Q3 2015 and fell as low as -$1.1 million in Q4 2016.
  • Historically, Net Equity Issued and Repurchased has averaged $1.3 million across 5 years, with a median of $350000.0 in 2017.
  • Across the five-year window, Net Equity Issued and Repurchased soared 233.33% in 2018 and slumped 60.0% in 2019, its largest moves.
  • Year by year, Net Equity Issued and Repurchased stood at $6.2 million in 2015, then tumbled by 117.74% to -$1.1 million in 2016, then jumped by 118.18% to $200000.0 in 2017, then soared by 50.0% to $300000.0 in 2018, then plunged by 33.33% to $200000.0 in 2019.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $200000.0 in Q4 2019, $400000.0 in Q3 2019, and $300000.0 in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Perrigo 1.40 Bn 1.05 Bn 325.50 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 200,000.00
Dec 31, 2019 200,000.00
Sep 28, 2019 400,000.00
Sep 28, 2019 400,000.00
Dec 31, 2018 300,000.00
Dec 31, 2018 300,000.00
Sep 29, 2018 1.00 Mn
Sep 29, 2018 1.00 Mn
Dec 31, 2017 200,000.00
Dec 31, 2017 200,000.00
Sep 30, 2017 300,000.00
Sep 30, 2017 300,000.00
Jul 1, 2017 200,000.00
Jul 1, 2017 200,000.00
Dec 31, 2016 -1.10 Mn
Dec 31, 2016 -1.10 Mn
Apr 2, 2016 3.10 Mn
Apr 2, 2016 3.10 Mn
Sep 26, 2015 6.20 Mn
Sep 26, 2015 6.20 Mn